(Q35138059)

6 August 2017

1 reference

title

Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus (English)

1 reference

6 August 2017

0 references

0 references

1

1 reference

29 October 2018

2

Erle S Robertson

1 reference

6 August 2017

1 May 2003

1 reference

FEMS Microbiology Letters

6 August 2017

1 reference

6 August 2017

222

1 reference

6 August 2017

2

1 reference

6 August 2017

155-163

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

6 August 2017

1 reference

7 January 2021

Influence of HIV infection on presentation of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

KSHV and Kaposi's sarcoma: the end of the beginning?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Viral exploitation and subversion of the immune system through chemokine mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

The descent of human herpesvirus 8.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900261-1

7 January 2021

10.1016/S0378-1097(03)00261-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12770701